two exciting new drugs for rheumatoid arthritis

September 1998

You'll soon see two exciting new drugs for rheumatoid arthritis...Arava (Ah-RAY-va, leflunomide) andEnbrel (EN-brel, etanercept).

These will be the first disease-modifying drugs for rheumatoid arthritis (RA) to be approved in over10 years.

Disease-modifying drugs actually slow joint destruction...aspirin and NSAIDs just relieve symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether hormone replacement therapy reduces the risk of heart disease
Antidepressants new antidepressant called Celexa (citalopram)
Antidepressants realizing that SSRI's can cause weight GAIN
Ophthalmology eye drop bottles don't last as long as they should
Cardiology recommendations for using Viagra in patients with heart disease
Cardiology warning that Ticlid can cause another serious blood disorder
saw palmetto provides SYMPTOMATIC benefit in men with benign prostatic hyperplasia (BPH)
More mainstream companies are now coming out with products that contain herbs
Breast Cancer more women with breast cancer treated with a bisphosphonate
Diabetes estrogen helps prevent and treat type 2 diabetes in postmenopausal women
Diabetes Many patients and clinics want to try the new Laser Lancet
Diabetes new warnings of liver dysfunction in patients taking Precose (acarbose)
New guidelines are now out for treating panic disorder
Women's Health CombiPatch, the first combination estrogen and progestin patch for menopausal symptoms
Women's Health Levlite, a new low-dose oral contraceptive
Rheumatoid Arthritis two exciting new drugs for rheumatoid arthritis
Ophthalmology new warnings about Xalatan and hyperpigmentation